Vanda Pharmaceuticals
VNDA
#8812
Rank
โ‚ฌ0.18 B
Marketcap
3,14ย โ‚ฌ
Share price
-6.13%
Change (1 day)
-29.53%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -โ‚ฌ0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.22 Billion. In 2025 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2024 earnings that were of -โ‚ฌ37.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.16 Billion12.05%
2025 -โ‚ฌ0.14 Billion271.79%
2024 -โ‚ฌ37.07 Million191.43%
2023 -โ‚ฌ12.72 Million-320.45%
2022 โ‚ฌ5.76 M-84.99%
2021 โ‚ฌ38.43 M54.8%
2020 โ‚ฌ24.83 M19.42%
2019 โ‚ฌ20.79 M4.93%
2018 โ‚ฌ19.81 M-228.6%
2017 -โ‚ฌ15.41 Million-8.98%
2016 -โ‚ฌ16.93 Million-53.79%
2015 -โ‚ฌ36.64 Million-30.18%
2014 -โ‚ฌ52.47 Million173.08%
2013 -โ‚ฌ19.22 Million-25.33%
2012 -โ‚ฌ25.73 Million163.61%
2011 -โ‚ฌ9.77 Million-221.15%
2010 โ‚ฌ8.05 M-124.53%
2009 -โ‚ฌ32.85 Million-29.44%
2008 -โ‚ฌ46.56 Million-36.2%
2007 -โ‚ฌ72.97 Million21.81%
2006 -โ‚ฌ59.9 Million170.55%
2005 -โ‚ฌ22.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B-10,622.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ11.52 B-7,206.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ6.35 B-4,016.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ31.69 B-19,643.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.12 B-3,878.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.33 B-6,469.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.56 Million-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA